APR 13, 2015 06:51 AM PDT

FDA Cites Diabetes Drug For Possible Increased Risk Of Death

WRITTEN BY: Judy O'Rourke

The agency's review of data on the drug Onglyza, from AstraZeneca, also found an increased risk of hospitalization due to heart failure. [Source: Newsy Science]
About the Author
  • Judy O'Rourke worked as a newspaper reporter before becoming chief editor of Clinical Lab Products magazine. As a freelance writer today, she is interested in finding the story behind the latest developments in medicine and science, and in learning what lies ahead.
You May Also Like
SEP 20, 2018
Videos
SEP 20, 2018
A Plant 'Nervous System' is Found
Learn more about how plants communicate....
SEP 25, 2018
Space & Astronomy
SEP 25, 2018
Japan Put Two Landers On An Asteroid for Science
Japanese space agency JAXA recently made history after its Hayabusa 2 mission approached the asteroid 162173 Ryugu and dumped off two landers to study the ...
OCT 03, 2018
Plants & Animals
OCT 03, 2018
These Weird Fish Live in Some of the Deepest Parts of the Ocean
While animal researchers are reasonably well-rounded about the types of species residing at mild depths, we still have a lot to learn about what inhabits t...
OCT 05, 2018
Videos
OCT 05, 2018
What is Site-directed Mutagenesis?
Site-directed mutagenesis is a common tool in the molecular laboratory. But someone had to pioneer it first....
OCT 12, 2018
Videos
OCT 12, 2018
Don't Mess With Microbes
Researchers demonstrate why antibiotics should not be used casually....
OCT 14, 2018
Videos
OCT 14, 2018
Globally, Many Students Are Over-Diagnosed With ADHD
When teachers notice issues with a student, parents naturally respond and often can lead to a diagnosis of ADHD. Now, a global study published in the Journ...
Loading Comments...